Bristol-Myers Squibb Company
Net Cash Flow Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
FY2009
FY2008
FY2007
Total Cash from Operations: $3.15B
| Line Item | Value | % of Total |
|---|---|---|
| Capital Expenditures | $592.2M | 18.8% |
| Business Acquisitions | $303.5M | 9.6% |
| Dividends Paid | $2.21B | 70.2% |
| Net Change in Short-Term Borrowings | $33.0M | 1.0% |
| Other Financing | $11.3M | 0.4% |
| Net Cash Flow | $0 | 0.0% |